Skip to content

Optimal dose of ciprofol for induction of anesthesia in older patients with hypertension: A Bayesian phase 1/2 trial

Optimal dose of ciprofol for induction of anesthesia in older patients with hypertension: A Bayesian phase 1/2 trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106208
Enrollment
Unknown
Registered
2025-07-21
Start date
2025-08-06
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Older patients with hypertension

Interventions

Intervention group:Anesthesia induction using ciprofol

Sponsors

The First Affiliated Hospital of Anhui Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Older patients (65–80 years) with hypertension scheduled for elective non-cardiac surgery requiring general anesthesia; 2. American Society of Anesthesiologists (ASA) physical status II or III; 3. Body mass index (BMI) of 18.0–30.0 kg/m^2; 4. Provided written informed consent.

Exclusion criteria

Exclusion criteria: 1. previous diagnosis of cerebral aneurysm or aneurysmal disease involving the thoracic or abdominal aorta; 2. known hypersensitivity to study medications; 3. severe hepatic or renal impairment (Child-Pugh class C or requirement for maintenance dialysis); 4. significant cardiovascular disease, including NYHA functional class III/IV, severe valvular disease, recent (within 6 months) myocardial infarction or unstable angina, frequent ventricular or atrial premature beats, atrial fibrillation, severe bradycardia (heart rate [HR] = 120 mmHg; 8. preoperative hemoglobin concentration < 10 g/dL; 9. known or predicted difficult airway; 10. frailty (FRAIL Scale score 3–5).

Design outcomes

Primary

MeasureTime frame
Post-induction hypotension (PIH);Successful induction;

Secondary

MeasureTime frame
Peak MAP within 3 minutes after tracheal intubation;Nadir HR during the observation window;Number of administrations of vasoactive drugs;Time from completion of initial ciprofol injection to LoC;The incidence and severity of injection pain;Nadir MAP during the observation window;BIS before tracheal intubation;

Countries

China

Contacts

Public ContactLijian Chen

The First Affiliated Hospital of Anhui Medical University

chenlijian77@126.com+86 139 6669 9467

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026